Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study

密歇根急诊科改进合作入院肺栓塞 (MEDIC ALERT PE) 研究

基本信息

项目摘要

PROJECT SUMMARY Of the 250,000 annual patients in the United States with acute pulmonary embolism (PE), the majority are at low risk for morbidity and mortality. In fact, evidence-based guidelines suggest that up to 50% of patients with an acute PE are at sufficiently low risk for complications that they can be safely managed without hospital admission. Yet fewer than 5% of patients nation-wide are currently discharged for outpatient management. Reliable access to anticoagulant medications and outpatient follow-up are commonly cited barriers to outpatient management. However, prevailing heuristics used by Emergency Medicine clinicians to enable rapid decision-making also firmly link acute PE with hospital admission, and likely makes behavior change for these busy clinicians more challenging. Multiple prior efforts to reduce hospital admission for low-risk patients with acute PE have been limited by single-center designs, inclusion of homogenous and highly-resourced health systems, or have lacked a robust implementation plan underpinning to their design and evaluation. Using the diverse, state-wide Michigan Emergency Department Improvement Collaborative (MEDIC), we will refine, tailor, and evaluate a multi-component intervention suitable for broad dissemination to increase the use of outpatient management of low-risk acute PE for patients presenting to the emergency department. Following an implementation mapping approach built upon published literature and our preliminary findings, our intervention will address key barriers identified by a diverse group of stakeholders by combining traditional implementation science and behavioral economics strategies. Importantly, electronic alerts will be informed by user-centered design approaches to fit within the clinician workflow and decision-making process and “right sized” to appear only for applicable patients. Evaluation will include both quantitative and qualitative elements from the RE-AIM implementation evaluation framework. This multi-component intervention will facilitate a patient-centered approach to clinical decision-making that improves value by reducing unnecessary hospitalization for patients with low-risk PE. Furthermore, by tailoring and evaluating this intervention within a diverse set of hospitals, our multi-component intervention will be well positioned for dissemination nation-wide. Finally, our use of multi-site implementation mapping will provide a blueprint for other multi-site collaboratives interested in improving outcomes for a broad array of clinical conditions through rigorous quality improvement and implementation initiatives.
项目概要 美国每年有 250,000 名急性肺栓塞 (PE) 患者,其中大多数处于 发病率和死亡率风险较低 事实上,基于证据的指南表明高达 50% 的患者患有此病。 急性肺栓塞发生并发症的风险足够低,无需住院即可安全治疗 然而,目前全国只有不到 5% 的患者出院接受门诊治疗。 可靠地获得抗凝药物和门诊随访是常见的障碍 然而,急诊医学顾客普遍使用启发法来实现快速治疗。 决策也将急性肺栓塞与入院紧密联系起来,并可能使这些人的行为发生改变 此前多次努力减少低风险患者的入院率。 急性肺栓塞受到单中心设计、同质和资源丰富的健康的限制 系统,或者缺乏支持其设计和评估的强有力的实施计划。 多元化、全州范围的密歇根急诊部改进合作组织 (MEDIC),我们将完善、 定制并评估适合广泛传播的多成分干预措施,以增加使用 对到急诊科就诊的患者进行低风险急性肺栓塞的门诊管理。 基于已发表的文献和我们的初步发现的实施映射方法,我们的 干预措施将通过结合传统的方法来解决不同利益相关者群体发现的主要障碍 重要的是,电子警报将由实施科学和行为经济学策略通知。 以用户为中心的设计方法,以适应临床医生的工作流程和决策过程以及“正确的” 大小”仅针对适用的患者出现 评估将包括定量和定性要素。 RE-AIM 实施评估框架的这一多组成部分干预措施将促进 以患者为中心的临床决策方法,通过减少不必要的干预来提高价值 低风险肺栓塞患者的住院治疗。此外,通过在一定范围内调整和评估这种干预措施 我们的多组成部分干预措施由多元化的医院组成,将能够在全国范围内传播。 最后,我们对多站点实施映射的使用将为其他多站点协作提供蓝图 有兴趣通过严格的质量改进来改善各种临床状况的结果 及实施建议。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Geoffrey Douglas Barnes其他文献

Geoffrey Douglas Barnes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Geoffrey Douglas Barnes', 18)}}的其他基金

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
为循证抗凝药物的使用实施处方者-药剂师协作护理
  • 批准号:
    10487496
  • 财政年份:
    2021
  • 资助金额:
    $ 70.82万
  • 项目类别:
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
为循证抗凝药物的使用实施处方者-药剂师协作护理
  • 批准号:
    10705628
  • 财政年份:
    2021
  • 资助金额:
    $ 70.82万
  • 项目类别:
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
为循证抗凝药物的使用实施处方者-药剂师协作护理
  • 批准号:
    10330852
  • 财政年份:
    2021
  • 资助金额:
    $ 70.82万
  • 项目类别:
Improving Safe Use of Direct Oral Anticoagulants: A Population Health Approach
提高直接口服抗凝剂的安全使用:人口健康方法
  • 批准号:
    10373967
  • 财政年份:
    2020
  • 资助金额:
    $ 70.82万
  • 项目类别:
Development of computer aided decision support and EHR alerts for DOAC prescribing
开发用于 DOAC 处方的计算机辅助决策支持和 EHR 警报
  • 批准号:
    10059571
  • 财政年份:
    2020
  • 资助金额:
    $ 70.82万
  • 项目类别:
Development of computer aided decision support and EHR alerts for DOAC prescribing
开发用于 DOAC 处方的计算机辅助决策支持和 EHR 警报
  • 批准号:
    10221047
  • 财政年份:
    2020
  • 资助金额:
    $ 70.82万
  • 项目类别:
Training to Advance Care Through Implementation Science in Cardiac And Lung Illnesses (TACTICAL)
通过在心脏和肺部疾病中实施科学来推进护理的培训(战术)
  • 批准号:
    10204091
  • 财政年份:
    2017
  • 资助金额:
    $ 70.82万
  • 项目类别:
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation
制定实施策略以改善心房颤动患者的围手术期抗凝管理
  • 批准号:
    10079024
  • 财政年份:
    2017
  • 资助金额:
    $ 70.82万
  • 项目类别:
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation
制定实施策略以改善心房颤动患者的围手术期抗凝管理
  • 批准号:
    9222184
  • 财政年份:
    2017
  • 资助金额:
    $ 70.82万
  • 项目类别:

相似国自然基金

巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
  • 批准号:
    82304503
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
  • 批准号:
    82374256
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
  • 批准号:
    82300771
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
  • 批准号:
    82374209
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Improving care transitions for Veterans withsocial needs
改善有社会需求的退伍军人的护理过渡
  • 批准号:
    10638723
  • 财政年份:
    2023
  • 资助金额:
    $ 70.82万
  • 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health TABA Supplement
使用 Jaspr Health TABA 补充剂治疗初级保健中的自杀驱动者
  • 批准号:
    10805635
  • 财政年份:
    2023
  • 资助金额:
    $ 70.82万
  • 项目类别:
COVID-19 Pandemic-related Changes in the Child Tax Credit and Effects on Behavioral Health for Medicaid-enrolled Adolescents
与 COVID-19 大流行相关的儿童税收抵免变化及其对参加医疗补助的青少年行为健康的影响
  • 批准号:
    10686628
  • 财政年份:
    2023
  • 资助金额:
    $ 70.82万
  • 项目类别:
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
  • 批准号:
    10759550
  • 财政年份:
    2023
  • 资助金额:
    $ 70.82万
  • 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
  • 批准号:
    10734831
  • 财政年份:
    2023
  • 资助金额:
    $ 70.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了